Clinical Decision Support for Ovarian Carcinoma Subtype Classification: A Pilot Observer Study With Pathology

Marios A Gavrielides1, Meghan Miller1, Ian S Hagemann1

  • 1From the Division of Imaging, Diagnostics, and Software Reliability, Office of Engineering and Science Laboratories (Dr Gavrielides and Ms Miller), and the Office of In Vitro Diagnostics and Radiological Health, Division of Molecular Genetics and Pathology (Dr Seidman), Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland; the Department of Bioengineering, University of Maryland, College Park (Ms Miller); and the Departments of Pathology and Immunology (Drs Hagemann, Abdelal, Alipour, Chen, Salari, Sun, and Zhou) and Obstetrics and Gynecology (Dr Hagemann), Washington University School of Medicine, St Louis, Missouri. Ms Miller is currently with PCTEST Engineering Laboratory, Columbia, Maryland.

Summary

Clinical decision support (CDS) tools can help less experienced pathologists improve diagnostic accuracy for complex cases like ovarian carcinoma. This study shows CDS systems have the potential to bridge knowledge gaps in pathology diagnostics.